CLDI

Calidi Biotherapeutics Inc

$0.27

-0.01 (-4.4%)

Analyst Overview

Target Price:

Date: 15.04.2026

$120.00

(+44493.1%)

Strong Buy: 0

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Description:

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. The company is headquartered in San Diego, California.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

BIOTECHNOLOGY

Address:

4475 EXECUTIVE DRIVE, SAN DIEGO, CA, UNITED STATES, 92121

Fiscal year end:

December

Market capitalization:

$3.07 Million

EBITDA:

-$18.6 Million

PERatio:

0.0

EPS:

-5.95

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

1.423

Dividends for 10 years

Income Statements for 10 years

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 5 years:

-100%

How much will you get:

Prices dates:

01-11-2021: $1,173.60 and 31-03-2026: $0.24